Obesity treatment using a Bioenterics intragastric balloon (BIB)--preliminary Croatian results.
ABSTRACT This study aims to assess the effectiveness, tolerance, safety, and patient satisfaction of obesity treatments using the Bioenterics intragastric balloon (BIB).
Prospective controlled trial of 33 obese patients who were treated with the BIB from March 2008 to March 2009 and who completed the 6 months treatment. Patients were selected on the basis of workup by a multidisciplinary team. The 33 obese patients (26 females, seven males) had a median age of 35 years (range 20-58). Their median baseline body weight (BW) was 114 kg (range 89-197) and their median body mass index (BMI) was 41.4 kg/m(2) (range 31.2-60.8).
Average weight reduction was 14 kg (range 2-37), loss total weight 10.1% (range 1.4-23.1), control BMI 35.6 kg/m(2) (range 29.4-50.3), delta BMI 4.5 (range 0.6-13.1), percentage excess weight loss 29.2 (range 2.8-53.6), and percent of excess BMI loss 29.3 (range 2.7-67.4). In one female patient the BIB was removed early due to intolerance. During the first week, minor side effects were noticed: nausea/vomiting occurred in 21 patients (63.6%), and abdominal cramps in 15 (45.5%). There was one balloon deflation and one impaction in the stomach. Those incidents were both successfully treated endoscopically. Patients had no major complications from mucosal lesions and no need for surgical interventions. All intragastric balloons were successfully removed endoscopically. Patients' treatment satisfaction correlated with the degree of BW loss (p = 0.0138).
BIB treatment in our setting showed the best results for individuals with BMI from 35 to 40 kg/m(2). Our preliminary results showed that BIB is safe, well tolerated with minor side effects, and alters quality of life for the better. The complication rate was negligible, due to the detailed pretreatment examinations and follow-up.
- SourceAvailable from: Mohamed Bekheit[Show abstract] [Hide abstract]
ABSTRACT: Abstract Background: The surgical management of morbid obesity is faced by several challenges. Alternative therapeutic strategies could have an important role in the perioperative risk reduction. The BioEnterics(®) intragastric balloon (BIB) (Inamed Health, Santa Barbara, CA) has been described as being effective in weight reduction and is used as a bridge before bariatric surgery. This study examined the efficacy of BIB in obese Egyptian patients and the value of the extended low caloric liquid diet program in weight loss. Subjects and Methods: A retrospective review of a prospectively maintained bariatric database was conducted. Weight changes and complications data were analyzed. Indications for BIB placement were discussed. Results: Records of 55 patients (11 males and 44 females) were retrieved. The mean initial body mass index (BMI) was 45.3±11 kg/m(2). The mean of excess body weight percentage was 111.96±53.2%. Nausea was reported in 30 patients (54.5%). Epigastric discomfort was reported in 23 patients (41.8 %), and vomiting was reported in 27 patients (49.1%). Six patients (10.9%) had an early removal of the balloon, whereas 4 (7.2%) had delayed removal (more than 6 months). The mean excess weight loss percentage (EWL%) was 17.2%. There was significant reduction in patients' BMI from 45.3 to 38.3 kg/m(2) (P<.001). There was no significant correlation between the EWL% and the gender, age, or initial BMI. Two patients had second balloon insertions without complications. There was no significant difference in the EWL% between the 1-week liquid diet group and the extended (4-week) low caloric diet group. Conclusions: The BIB is effective and safe in weight reduction in obese Egyptian patients. The impact of extended liquid dieting period is not significant.Journal of Laparoendoscopic & Advanced Surgical Techniques 12/2012; · 1.07 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Quality of life of the obese patients after treatment with insertion of intragastric BIB balloon versus Atkins diet in Al Sulaimaneyah province-Iraq Hiwa O. Ahmed University of Al Sulaimaneyah .Faculty of Medicine,School of Medicine PB 13,Al Sulaimaneyah,Iraq Tel; 009647701530753 Abstract Background ; Health related quality of life (HRQOL) is studied widely, after weight loss by insertion of BioEnterics Intragastric Balloon,but quality of life (QOL) not related to the health of the patients is not studied after body weight loss by any means on wide scale. Aim: To evaluate extend of body weight loss in general and particularly after BIB insertion or Atkins diet and changes of quality of life in the obese patients after body weight loss. Patients, materials and methods: Prospective study, from a total of 180 patients, 80 of them selected over a period of 4 years, included patients divided in to two comparable groups, first treated with insertion of Bioenterics intragastric balloon and the second subjected to modified Atkins diet for 6 months. Each patient in either group followed up monthly for 18 months ,the patients were interviewed before the star and after completion of the treatments to fill the quality of life questionnaire. The collecting data were analyzed using the IBM SPSS ( statistical package for social science) statistics version 21. Results: Two comparable groups of obese patients were studied, each group consists of 40 female patients, mean age in group A was 27years (20-39 years) with mean body weight 90 kg (80-100) and mean BMI 36(31-39.9) who were treated with insertion of BIB. While mean age in group B was 29 years (20-39 years) with mean body weight 91 kg (80-102) and mean BMI 36.5 (31-39.9). Statistically important changes occurred in the quality of life of the patients after either method of treatments to different degrees (p value 0.005917) Conclusion: BioEnterics Intragastric Balloon reduces more weight and BMI in 6 months in comparison to modified Atkins diet, and results in statistically significant improvement of most aspects of quality of life. Keywords: obesity, quality of life, loss of weight, BioEnterics Intragastric Balloon, Atkins diet. BioEnterics Intragastric BalloonFood Science and Quality Management. 10/2013; 20:29-36.
- [Show abstract] [Hide abstract]
ABSTRACT: GROWING WORLDWIDE OBESITY EPIDEMIC HAS PROMPTED THE DEVELOPMENT OF TWO MAIN TREATMENT STREAMS: (a) conservative approaches and (b) invasive techniques. However, only invasive surgical methods have delivered significant and sustainable benefits. Therefore, contemporary research exploration has focused on the development of minimally invasive gastric manipulation methods featuring a safe but reliable and long-term sustainable weight loss effect similar to the one delivered by bariatric surgeries. This antiobesity approach is based on placing external devices in the stomach ranging from electrodes for gastric electrical stimulation to temporary intraluminal bezoars for gastric volume displacement for a predetermined amount of time. The present paper examines the evolution of these techniques from invasively implantable units to completely noninvasive patient-controllable implements, from a functional, rather than from the traditional, parametric point of view. Comparative discussion over the available pilot and clinical studies related to gastric electrical stimulation outlines the promises and the fallacies of this concept as a reliable alternative anti-obesity strategy.ISRN gastroenterology. 01/2013; 2013:434706.